• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biotech and Pharmaceuticals

Recent news which mentions Biotech and Pharmaceuticals

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
32 33 Next >
Eli Lilly CEO expects new weight loss pill to be approved next year
January 13, 2025
Tags Breaking News: Business Business News Business
From CNBC.com News
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
January 13, 2025
Tags Business Companies Biotechnology
From CNBC.com News
Walgreens results top estimates as drugstore chain works to slash costs
January 10, 2025
Tags Dividends Health & Science Business
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags Health & Science Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags Pfizer Inc Madrigal Pharmaceuticals Inc Health care industry
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
January 07, 2025
Tags Health & Science Health care industry Johnson & Johnson
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags Biotechnology Companies Business
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
Tags Biotechnology Science Companies
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
December 20, 2024
Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
Tags Pharmaceuticals Biotech and Pharmaceuticals US: News
From CNBC.com News
Why Americans are outraged over health insurance — and what could change
December 18, 2024
Tags Pharmaceuticals Health & Science UnitedHealth Group Inc
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
December 18, 2024
Tags Pfizer Inc Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
December 17, 2024
Tags Social issues Novo Nordisk A/S Health & Science
From CNBC.com News
UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is 'flawed'
December 13, 2024
Tags UnitedHealth Group Inc Health & Science Pharmaceuticals
From CNBC.com News
Health care stocks fall as lawmakers, patients push for changes to their business models
December 11, 2024
Tags Pharmaceuticals Health & Science UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
Tags Social issues Novo Nordisk A/S Health & Science
From CNBC.com News
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
32 33 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap